Anti-Snoring Devices Market Going Smart with Smart CPAP & AutoPAP. The Market Revenue to Reach $1.81 Billion by 2027- Arizton

Arizton's latest research report states that the anti-snoring devices market will grow at a CAGR of 8% during 2022-2027. The global anti-snoring devices market by PAP devices is estimated to grow 1.4X times. The adoption rate of PAP devices is higher in North America and Europe, and it is expected that the APAC region will witness faster adoption of PAP devices during the forecast period. In developed regions, such as North America and Europe, anti-snoring devices are already popular for snoring and OSA.

Anti Snoring Device Market
Anti Snoring Device Market
State-of-the-art CPAP and APAP machines include microprocessors that enable high-density data storage, internal self-tests to ensure that hardware and software are functioning correctly, and patient usage specifics. It contains several reports that can detail parameters. This allows clinicians to track patient compliance and track usage on an hourly, daily, weekly, or monthly basis. Compliance measurements are more accurate by recording mask-on-time instead of on time (used in older CPAP models through a digital meter). Thus, the advantages of CPAP and APAP devices are expected to increase their demand during the forecast period.

The market is currently witnessing the entry of many new players. Start-ups promise to provide different products to meet customer demand and market trends. Smart anti-snoring devices are gaining high traction globally as they are explored by existing and new players. The cutting-edge concept, which involves enhancing the functionality of regularly used gadgets and making them perform better than intended, includes smart anti-snoring devices. IoT connectivity options allow these devices to connect with other devices, enhancing their fundamental capabilities and making them user-friendly.

The anti-snoring device market has been witnessing technological advancement in product offerings, such as the launch of innovative devices which is integrated with muscle stimulation that provide nerve-muscle stimulation of the tongue to lower snoring and mild sleep apnea, apart from that, start-ups focus on the development of smart bedding, mattresses, pillows, and other sleep devices. These devices are well-developed to help decrease snoring and give snorers and their partners' comfortable sleep. Therefore, sleep-based start-ups are expected to account for a significant share of the global anti-snoring devices market.

For instance, Smart Nora is a Toronto-based start-up focused on sleep and health. Launched initially in the Kickstarter campaign, the Smart Nora Snoring Solution is now the company's only product. This device is designed to stop snoring before the snorer wakes up. Smart Nora uses air pressure to raise and lower the pillow slightly, activating throat muscles that help prevent snoring. This technology is different from other anti-snoring devices. Smart Nora is ideal for sleepers who want to minimize sleep problems caused by snoring but do not want to wear the device at bedtime. Smart Nora is designed to work with any pillow and any sleeping position.

The anti-snoring device market witnesses continued product launches with the growth in the demand for compact and smart devices. Companies invest significant effort and money to launch new, advanced anti-snoring devices to meet the needs of a large patient pool, especially undiagnosed patients. These ongoing product launches will boost the growth of the global anti-snoring device market.

Recent Developments
In May 2022, Illusion Aligners launched a new innovative anti-snoring device. This Illusion Aligner oral anti-snoring device is easy to wear, effective, and comfortable. It helps the user to experience an undisturbed and peaceful sleep every night.
In February 2021, Signifier Medical Technologies launched an innovative anti-snoring device, eXciteOSA, and the device works by producing electrical muscle stimulation through a mouthpiece around the tongue. The device has four electrodes, two located above the tongue and two below the tongue. The U.S. FDA approved the commercialization of a prescription-only anti-snoring device, ''eXciteOSA''.
Market Segmentation

Product
Oral Devices
Pap Devices
Nasal Devices
Others

Application
Body Contouring & Cellulite Reduction
Skin Tightening & Skin Lighteners
Facial Aesthetic
Breast Augmentation
Others

Age Group
Between 40 & 59 Years
60 & Above Years
Below 40 Years

Gender
Men
Women

End User
Sleep Labs & Dental Clinics
Home Healthcare
Hospitals

Looking for Free Sample Report? Click: https://www.arizton.com/request-sample/3558

In the global market for anti-snoring devices, North America reported a significant share of 33.31% in 2021. Numerous factors, including the high prevalence of sleep disorders, declining sleep patterns, lifestyle changes, and numerous vendors, including key players, start-ups, and sleep-related businesses, are favorable to the market growth. In North America, 10 to 15% of women and close to 15% of men suffer from Obstructive sleep apnea (OSA). The North American region has a higher percentage of OSA, snoring, and anti-snoring device manufacturers than any other region in the world, which is increasing the region's market share. Moreover, due to societal changes and the sedentary lifestyle of the population, the United States is expected to generate the highest Revenue in the North American region.

Asia Pacific, which currently holds a 22.6% market share for anti-snoring devices worldwide, is expected to record USD 443.9% by 2027. APAC nations are currently experiencing a rapidly aging population, which increases the prevalence of sleeping disorders. There have been more cases of mental health issues across APAC due to work-related stress and loneliness, which are the major impact of the COVID-19 pandemic. The anti-snoring device market growth in this region is attributed to the manufacturing power of the countries involved in APAC, such as China, Japan, and India. However, Japan has one of the highest prevalences of mental health issues and one of the highest rates of work-related stress. Thereby, the demand for anti-snoring devices across the APAC market to grow at a faster rate.

Know more about the market: https://www.arizton.com/market-reports/anti-snoring-devices-market

Geography
North America
The U.S.
Canada

Europe
Germany
France
UK
Italy
Spain

APAC
Japan
China
India
South Korea
Australia

Latin America
Brazil
Mexico
Argentina

Middle East & Africa
Turkey
Saudi Arabia
South Africa

Vendors Profiled in the Report
Apnea Science
ResMed
Koninklijke Philips N.V
Fisher & Paykel
Tomed
Illusion Aligners
Sleep Number
VVFLY Electronics
Signifier Medical Technologies
Glidewell
Smart Nora
ProSomnus
SomnoMed
REM-Fit
Downtown Denver Sleep Solutions
MEDITAS
ApneaMed
Wolfson Holdco
Rhinomed
DeVilbiss Healthcare
White Dental Healthcare
Hupnos
Nitetronic
Nyxoah
Oventus
Vivos Therapeutics
Somnowell
ZQuiet
RemSleep Holdings
Humetron
Nidra Care

Table of Content
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSION
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
7.1 MARKET OVERVIEW
7.1.1 MARKET DYNAMICS INSIGHTS
7.1.2 ANTI-SNORING DEVICES: MARKET SEGMENTATION
7.1.3 VENDOR ANALYSIS
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 EMERGENCE OF SMART ANTI-SNORING DEVICES
9.2 ENTRY OF SLEEP-BASED START-UPS
9.3 ADVENT OF LATEST-GENERATION HERBST-STYLE ORAL APPLIANCES
9.4 APPROVAL & LAUNCH OF LATEST ANTI-SNORING DEVICES
10 MARKET GROWTH ENABLERS
10.1 ONLINE PURCHASE OF ANTI-SNORING DEVICES
10.2 AWARENESS OF ADVERSE EFFECTS OF SNORING
10.3 LARGE TARGET PATIENT POPULATION
10.4 TECHNOLOGICAL ADVANCES IN CPAP THERAPY
11 MARKET RESTRAINTS
11.1 HIGH COST OF ADVANCED ANTI-SNORING DEVICES
11.2 AVAILABILITY OF SURGICAL OPTIONS TO TREAT SNORING
11.3 LOW PATIENT COMPLIANCE WITH CPAP THERAPY
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 MARKET SIZE & FORECAST
12.1.2 INSIGHTS BY GEOGRAPHY
12.1.3 INSIGHTS BY PRODUCT
12.1.4 INSIGHTS BY AGE
12.1.5 INSIGHTS BY GENDER
12.1.6 INSIGHTS BY END-USER
12.2 FIVE FORCES ANALYSIS
12.2.1 THREAT OF NEW ENTRANTS
12.2.2 BARGAINING POWER OF SUPPLIERS
12.2.3 BARGAINING POWER OF BUYERS
12.2.4 THREAT OF SUBSTITUTES
12.2.5 COMPETITIVE RIVALRY
13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 ORAL DEVICES
13.4 PAP DEVICES
13.5 NASAL DEVICES
13.6 OTHERS
14 AGE
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 BETWEEN 40 & 59 YEARS
14.4 60 YEARS & ABOVE
14.5 BELOW 40 YEARS
15 GENDER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 MEN
15.4 WOMEN
16 END-USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 SLEEP LABS & DENTAL CLINICS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 HOME HEALTHCARE SETTINGS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 HOSPITALS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 KEY COUNTRIES
18.3.1 US: MARKET SIZE & FORECAST
18.3.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 KEY COUNTRIES
19.3.1 GERMANY: MARKET SIZE & FORECAST
19.3.2 FRANCE: MARKET SIZE & FORECAST
19.3.3 UK: MARKET SIZE & FORECAST
19.3.4 ITALY: MARKET SIZE & FORECAST
19.3.5 SPAIN MARKET SIZE & FORECAST
20 ASIA PACIFIC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 KEY COUNTRIES
20.3.1 CHINA: MARKET SIZE & FORECAST
20.3.2 JAPAN: MARKET SIZE & FORECAST
20.3.3 INDIA: MARKET SIZE & FORECAST
20.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.3.5 AUSTRALIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 KEY COUNTRIES
21.3.1 BRAZIL: MARKET SIZE & FORECAST
21.3.2 MEXICO: MARKET SIZE & FORECAST
21.3.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 KEY COUNTRIES
22.3.1 TURKEY: MARKET SIZE & FORECAST
22.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
24 KEY COMPANY PROFILES
24.1 APNEA SCIENCES
24.2 RESMED
24.2.2 RESMED IN GLOBAL ANTI-SNORING DEVICES MARKET
24.3 KONINKLIJKE PHILIPS N.V
24.3.3 PRODUCT OFFERINGS
24.4 FISHER & PAYKEL HEALTHCARE
24.5 TOMED
25 OTHER PROMINENT VENDORS
25.1 ILLUSION ALIGNERS
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 SLEEP NUMBER
25.3 VVFLY ELECTRONICS
25.4 SIGNIFIER MEDICAL TECHNOLOGIES
25.5 GLIDEWELL
25.6 SMART NORA
25.7 PROSOMNUS
25.8 SOMNOMED
25.9 REM-FIT
25.10 DOWNTOWN DENVER SLEEP SOLUTIONS
25.11 MEDITAS
25.12 APNEAMED
25.13 WOLFSON HOLDCO
25.14 RHINOMED
25.15 DEVILBISS HEALTHCARE
25.16 WHITE DENTAL HEALTHCARE
25.17 HÜPNOS
25.18 NITETRONIC
25.19 NYXOAH
25.20 OVENTUS
25.21 VIVOS THERAPEUTICS
25.22 SOMNOWELL
25.23 ZQUIET
25.24 REMSLEEP HOLDINGS
25.25 HUMETRON
25.26 NIDRA CARE
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY PRODUCT
27.1.1 NORTH AMERICA
27.1.2 EUROPE
27.1.3 APAC
27.1.4 LATIN AMERICA
27.1.5 MIDDLE EAST & AFRICA
27.2 MARKET BY AGE
27.2.1 NORTH AMERICA
27.2.2 EUROPE
27.2.3 APAC
27.2.4 LATIN AMERICA
27.2.5 MIDDLE EAST & AFRICA
27.3 MARKET BY GENDER
27.3.1 NORTH AMERICA
27.3.2 EUROPE
27.3.3 APAC
27.3.4 LATIN AMERICA
27.3.5 MIDDLE EAST & AFRICA
27.4 MARKET BY END-USER
27.5 NORTH AMERICA
27.5.1 EUROPE
27.5.2 APAC
27.5.3 LATIN AMERICA
27.5.4 MIDDLE EAST & AFRICA
27.6 MARKET BY GEOGRAPHY
27.6.1 ORAL DEVICES
27.6.2 PAP DEVICES
27.6.3 NASAL DEVICES
27.6.4 OTHERS
27.6.5 BETWEEN 40 & 59 YEARS
27.6.6 60 YEARS & ABOVE
27.6.7 BELOW 40 YEARS
27.6.8 MEN
27.6.9 WOMEN
27.6.10 SLEEP LABS & DENTAL CLINICS
27.6.11 HOME HEALTHCARE SETTINGS
27.6.12 HOSPITALS
28 APPENDIX
28.1 ABBREVIATIONS

About Us:     
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, IT and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Call: +1-312-235-2040  / +1 302 469 0707  
Mail: enquiry@arizton.com

This release was published on openPR.